Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate 0.015% for Actinic Keratosis of the Chest
NCT02446223Phase 4Completed
- Sponsor
- Cosmetic Laser Dermatology
- Start
- Jan 2015
- Primary completion
- Sep 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Cosmetic Laser Dermatology. Started Jan 2015; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02446223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446223.